GE HealthCare Technologies Inc. with ticker code (GEHC) have now 12 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $97.00 and $66.00 calculating the average target price we see $82.54. Given that the stocks previous close was at $69.41 this would indicate that there is a potential upside of 18.9%. It’s also worth noting that there is a 50 day moving average of $68.38 and the 200 day MA is $74.49. The market cap for the company is 31.58B. The current share price for the company is: $69.37 USD
The potential market cap would be $37,554,105,509 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 20.58, revenue per share of $42.36 and a 6.17% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
